Announcing the 10th Pilot Grant Cohort Advancing the Treatment of Substance Use Disorders, HCV, and HIV
CHERISH is excited to welcome a new pilot grant cohort for the 10th year. Spearheaded by CHERISH Pilot Grant Program Director Brandon Aden, the program is designed to help researchers gain familiarity with health economic evaluations, apply related methodologies to their pilot research, and build out the next stage of their careers. This year, CHERISH […]
Improving Care for Opioid Use Disorder in the Criminal-Legal System
Substance use disorders (SUD), and especially opioid use disorder (OUD), are prevalent within the criminal-legal system. Recently, there has been increased alignment of OUD care across the criminal-legal system with the patient-centered American Society of Addiction Medicine guidelines. Whether by choice or through legislation, carceral facilities are increasingly offering FDA-approved medications for OUD (MOUD), which […]
Sean M. Murphy and Chelsea L. Shover Receive Inaugural NIH HEAL Director’s Award and Trailblazer Award
The 4th Annual NIH Helping to End Addiction Long-Term (HEAL) Initiative Investigator Meeting took place on February 22, 2023. HEAL-funded investigators and key stakeholders gathered in Bethesda, MD, to share research findings and identify new opportunities for pain and opioid use disorder research. HEAL Director Dr. Rebecca Baker also presented the inaugural NIH HEAL Initiative Director’s Awards for […]
Will States and Counties Spend Their National Opioid Settlements Effectively?
As $54 billion in National Opioid Settlement funds begin moving out toward states, counties, and municipalities, there is widespread concern among health authorities that the legal victory does not become a repeat of the 1998 mega-billion-dollar Tobacco Master Settlement Agreement fiasco in which most states used the money for just about everything except tobacco cessation […]
Budget Impact Tool for the Incorporation of Medications for Opioid Use Disorder into Jail/Prison Facilities
Despite evidence that medications for opioid use disorder (MOUD), namely methadone, buprenorphine, and naltrexone, provided at the point of incarceration improve the well-being of the individual and the public, financial and administrative limitations in jail/prison healthcare often serve as barriers to this recommended first-line treatment for OUD. In fact, evidence indicates that more than 80% […]
Cost-effectiveness of Extended-release Injectable Naltrexone among Incarcerated Persons with Opioid Use Disorder Before Release from Prison Versus After Release
Compared to the general population, individuals with opioid use disorder (OUD) who are involved with the criminal-legal system have a much higher risk of a fatal overdose after release from incarceration. Yet, stigma, costs, and preferences for non-narcotic treatments in criminal-legal settings have stalled the implementation of life-saving treatment within the criminal-legal system. Extended-release naltrexone […]
Intern Spotlight: Grace L. Edwards, Jessica Girard, Lyric Harris, and Antara Saha
The Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH) is delighted to welcome four astounding interns this summer: Grace L. Edwards, Jessica Girard, Lyric Harris, and Antara Saha. Setting personal goals to pursue medical journalism, forensic psychiatry, nursing, and a doctoral degree in developmental psychopathology, they applied through […]
Why Does the Opioid Mortality Rate Continue to Rise?
From April 2020 through April 2021, there were 100,300 drug overdose deaths across the country according to the CDC — a 28.5% increase over the previous year. Some 75% of these were opioid-related overdoses that killed an average of nine users an hour around the clock throughout the year. Looking forward, the just-published Stanford-Lancet Commission on […]
Advancing Evidence-Based Substance Use Disorder Treatment Policies
If you want to reform state laws to require detox facilities to include medications like buprenorphine and methadone in their treatments, you should start by changing the “hearts and minds” of those who oppose it, Rebekah Gee, MD, MPH, MHSPR, told the January 14, 2022 Penn LDI/CHERISH Virtual Conference at the University of Pennsylvania. Keynoting a gathering organized […]
Achieving Value in Substance Use Disorder Treatment: Paying for What Works (and Not Paying for What Doesn’t): Workshop Summary
More than 100 policymakers, practitioners, and researchers discussed and debated how payment policy can promote evidence-based, cost-effective substance use disorder treatment, in a recent workshop hosted by the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV and HIV (CHERISH) and the Leonard Davis Institute of Health Economics at the University of […]
CHERISH Investigators and Research Affiliates Support NIDA Justice Community Opioid Innovation Network (JCOIN)
On July 24 2019, the National Institute on Drug Abuse (NIDA) announced twelve grants totaling approximately $155 million for the Justice Community Opioid Innovation Network (JCOIN) as part of the greater NIDA HEAL initiative. JCOIN will establish a network of 10 clinical research institutions, a Methodology and Advanced Analytics Resource Center (MAARC), and a Coordination and Translation Center (CTC) that […]
Engage with CHERISH
Submit a Consultation Request or Contact Us to learn more about how CHERISH can support your research or policy goals.